BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38608449)

  • 21. Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.
    Paolella G; Sposito S; Romanelli AM; Caputo I
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celiac disease 2015 update: new therapies.
    Veeraraghavan G; Leffler DA; Kaswala DH; Mukherjee R
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):913-27. PubMed ID: 25864708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.
    Iversen R; Fleur du Pré M; Di Niro R; Sollid LM
    J Immunol; 2015 Dec; 195(11):5159-68. PubMed ID: 26503953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detoxification of gluten by means of enzymatic treatment.
    Wieser H; Koehler P
    J AOAC Int; 2012; 95(2):356-63. PubMed ID: 22649919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
    Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
    PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celiac Disease in Children.
    Jimenez J; Loveridge-Lenza B; Horvath K
    Pediatr Clin North Am; 2021 Dec; 68(6):1205-1219. PubMed ID: 34736585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment.
    Verdu EF; Schuppan D
    Gastroenterology; 2021 Nov; 161(5):1395-1411.e4. PubMed ID: 34416277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic options for coeliac disease: What else beyond gluten-free diet?
    Caio G; Ciccocioppo R; Zoli G; De Giorgio R; Volta U
    Dig Liver Dis; 2020 Feb; 52(2):130-137. PubMed ID: 31831308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Celiac disease : Pathogenesis, clinics, epidemiology, diagnostics, therapy].
    Schuppan D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jul; 59(7):827-35. PubMed ID: 27273303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of modified versus unmodified wheat gluten administration in patients with celiac disease.
    Marino M; Casale R; Borghini R; Di Nardi S; Donato G; Angeloni A; Moscaritolo S; Grasso L; Mazzarella G; Di Tola M; Rossi M; Picarelli A
    Int Immunopharmacol; 2017 Jun; 47():1-8. PubMed ID: 28343108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge.
    Adriaanse MP; Leffler DA; Kelly CP; Schuppan D; Najarian RM; Goldsmith JD; Buurman WA; Vreugdenhil AC
    Am J Gastroenterol; 2016 Jul; 111(7):1014-22. PubMed ID: 27185075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
    Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive Macaques.
    Sestak K; Thwin H; Dufour J; Liu DX; Alvarez X; Laine D; Clarke A; Doyle A; Aye PP; Blanchard J; Moehs CP
    Nutrients; 2016 Jun; 8(7):. PubMed ID: 27367722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nutritional Consideration in Celiac Disease and Nonceliac Gluten Sensitivity.
    Naik RD; Seidner DL; Adams DW
    Gastroenterol Clin North Am; 2018 Mar; 47(1):139-154. PubMed ID: 29413009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the development of new treatments for celiac disease.
    Lähdeaho ML; Lindfors K; Airaksinen L; Kaukinen K; Mäki M
    Expert Opin Biol Ther; 2012 Dec; 12(12):1589-600. PubMed ID: 22928821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gluten tolerance in adult patients with celiac disease 20 years after diagnosis?
    Hopman EG; von Blomberg ME; Batstra MR; Morreau H; Dekker FW; Koning F; Lamers CB; Mearin ML
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):423-9. PubMed ID: 18403944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celiac Disease and Nonceliac Gluten Sensitivity: A Review.
    Leonard MM; Sapone A; Catassi C; Fasano A
    JAMA; 2017 Aug; 318(7):647-656. PubMed ID: 28810029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
    Koning F; Gilissen L; Wijmenga C
    Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Celiac Disease and Gluten Sensitivity.
    DeGeorge KC; Frye JW; Stein KM; Rollins LK; McCarter DF
    Prim Care; 2017 Dec; 44(4):693-707. PubMed ID: 29132529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management.
    Schuppan D; Dennis MD; Kelly CP
    Nutr Clin Care; 2005; 8(2):54-69. PubMed ID: 16013224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.